- Home
- IGC vs CNF Comparison
IGC vs CNF Comparison
Compare IGC & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- CNF
- Stock Information
- Founded
- IGC 2005
- CNF 1999
- Country
- IGC United States
- CNF China
- Employees
- IGC N/A
- CNF N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- CNF Finance: Consumer Services
- Sector
- IGC Health Care
- CNF Finance
- Exchange
- IGC Nasdaq
- CNF Nasdaq
- Market Cap
- IGC 33.8M
- CNF 35.7M
- IPO Year
- IGC N/A
- CNF 2018
- Fundamental
- Price
- IGC $0.32
- CNF $5.00
- Analyst Decision
- IGC Strong Buy
- CNF
- Analyst Count
- IGC 2
- CNF 0
- Target Price
- IGC $4.00
- CNF N/A
- AVG Volume (30 Days)
- IGC 703.5K
- CNF 7.5K
- Earning Date
- IGC 11-17-2025
- CNF 08-28-2025
- Dividend Yield
- IGC N/A
- CNF N/A
- EPS Growth
- IGC N/A
- CNF N/A
- EPS
- IGC N/A
- CNF N/A
- Revenue
- IGC $1,106,000.00
- CNF $50,241,013.00
- Revenue This Year
- IGC $3.54
- CNF $252.34
- Revenue Next Year
- IGC $15.12
- CNF N/A
- P/E Ratio
- IGC N/A
- CNF N/A
- Revenue Growth
- IGC N/A
- CNF N/A
- 52 Week Low
- IGC $0.25
- CNF $2.36
- 52 Week High
- IGC $0.50
- CNF $13.90
- Technical
- Relative Strength Index (RSI)
- IGC 27.94
- CNF 51.40
- Support Level
- IGC $0.31
- CNF $4.34
- Resistance Level
- IGC $0.33
- CNF $5.40
- Average True Range (ATR)
- IGC 0.02
- CNF 0.30
- MACD
- IGC -0.01
- CNF -0.04
- Stochastic Oscillator
- IGC 8.50
- CNF 49.12
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.